Quarterly report pursuant to Section 13 or 15(d)

SCHEDULE OF SHARE BASED AWARDS (Details)

v3.22.1
SCHEDULE OF SHARE BASED AWARDS (Details)
3 Months Ended
Mar. 31, 2022
$ / shares
shares
Equity [Abstract]  
Number of warrants outstanding, ending balance | shares 450,000
Weighted average exercise price, ending balance | $ / shares $ 1.38
Weighted average remaining life, ending balance 4 years 3 months 18 days
Number of warrants exercisable, ending balance | shares 175,000,000
Weighted average exercise price exercisable, ending balance | $ / shares $ 2.22
Weighted average remaining life, exercisable 4 years 3 months 18 days